Indocyanine Green Market projected to hit USD 202.4 Billion in 2023, growing at a 8.7% CAGR. Explore in-depth industry size, share, key segments, top players, and forecast trends from 2024 to 2033 in this latest market research report.

Indocyanine Green Market Size, Trends and Analysis Report 2033

&nbsp;
Indocyanine Green (CAS 3599-32-4) market Synopsis
&nbsp;
The global Indocyanine Green (CAS 3599-32-4) market was valued at USD 202.4 Million in 2023 and expected to grow from USD 220.0 Million in 2024 to USD 466.1 Million by 2033, reflecting a CAGR of 8.7% over the forecast period.
&nbsp;
Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.&nbsp;Akorn is the dominate producer of indocyanine green, the production was 536.6 K NOS in 2015, accounting for about 25.80% of the total amount, followed by PULSION Medical Systems AG, with the production market share of 16.19%.
&nbsp;
Global Indocyanine Green (CAS 3599-32-4) Market Report is a detailed and comprehensive examination of the Indocyanine Green (CAS 3599-32-4) industry that offers valuable insights to businesses, investors, policymakers, and other stakeholders. This exhaustive research is a strategic identification of market actual status, future outlook, major trends, challenges, and opportunities. The Indocyanine Green (CAS 3599-32-4) report acts as a crucial instrument for top management to make well-thought decisions using reliable, factual data analysis of the marketplace at the global, regional, and country levels. A distinguishing characteristic of the report is its estimate of the market size which gives a figure of the US dollar value of the Indocyanine Green (CAS 3599-32-4) market. This contains a thorough analysis of the past, present, and future development of the market, hence provides a complete understanding of the market growth pattern over the specified period. Provided financial indicators enable the stakeholders to keep an eye on the market's progression, estimate the market size, and predict the long-term growth prospects.
&nbsp;
<img src="../media/static/87f39451961a4d73824105588bde9ddd2025_05_21_14_46_12_946047.png" alt="Indocyanine Green&nbsp;Market Overview" width="1397" height="615">
&nbsp;
The Indocyanine Green (CAS 3599-32-4) report is an in-depth examination of market dynamics in light of the main forces creating the industry. The latter includes market drivers for example technological innovations, rising customer demand, government support, and lifestyle changes that move the industry forward. Besides, it is revealed in the study that theoretically equally the market restraints might consist of factors like strict government regulations, economic downturn, deficient supply chain, and competitor&rsquo;s pressures that lead to the market slowing down. Similarly, the Indocyanine Green (CAS 3599-32-4) market report shows the possibility stages as of new markets, innovative features of the products, and the latest digital trends in the transformation market as well as the challenges of material cost fluctuations and geopolitical uncertainties. The facts contained in the report will make it possible for business to come up with the strategies of increasing the chances of growth and solving the potential risks.
&nbsp;
Another section of the Indocyanine Green (CAS 3599-32-4) market report is dedicated to the analysis of individual segments, where the market is broken down into several sub-segments based on such parameters as product type, application, end-use industry, and distribution channels. Every sub-segment is analysed in terms of value and share, hence, the stakeholders are empowered to identify the areas of good return and rapid growth only. The comparison of these sub-segments in addition to giving the market situation thus helps the enterprises to be informed about the most competitive goods and the most suitable investment positions in the global Indocyanine Green (CAS 3599-32-4) market space.
&nbsp;
Market Segment by Type
 &nbsp;&nbsp;&nbsp; Type I &nbsp;&nbsp;&nbsp; Type II Market Segment by Applications
 &nbsp;&nbsp;&nbsp; Ophthalmology &nbsp;&nbsp;&nbsp; Neurosurgery &nbsp;&nbsp;&nbsp; Liver Diseases &nbsp;&nbsp;&nbsp; Others
&nbsp;
The regional section of the report provides a distribution of the Indocyanine Green (CAS 3599-32-4) market according to different locations, regions, and countries such as North America, Europe, Asia-Pacific, Latin America, and the Middle East &amp; Africa. The report unveils market size, share, and growth patterns for each region and key countries thus allowing the sectors to identify drivers, evaluate available opportunities, and make suitable strategies. Also, it deals with region-based traits like economic vibes, legal standing, and socio-cultural elements as well as the degree of competition.
&nbsp;
By Region
&nbsp;
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
Middle East &amp; Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
South America (Brazil, Argentina, Rest of SA)
&nbsp;
In addition to above, the significant part (which is included in the research) is a competitive analysis of the landscape that presents in detail the profile of the top companies in the Indocyanine Green (CAS 3599-32-4) market. The profiles are made up of a company overview of each company, a listing of the company's products, the financial performance of the company, the strategies the company will execute, and the recent developments of the company. The report also puts forward company-wise market share in order to disclose the competitive positioning of the top players. The deeper understanding of the aforementioned changes allows sectors to compare their performance, pull knowledge from the market leaders, and come up with competitive strategies, not only limited to innovation, mergers, partnerships but also expansions.
&nbsp;
Active Key Players in the Indocyanine Green (CAS 3599-32-4) Market&nbsp;
&nbsp;
&nbsp; &nbsp; Akorn &nbsp;&nbsp;&nbsp; PULSION Medical Systems AG &nbsp;&nbsp;&nbsp; Diagnostic Green &nbsp;&nbsp;&nbsp; SERB &nbsp;&nbsp;&nbsp; Daiichi Sankyo Company &nbsp;&nbsp;&nbsp; Santen Pharmaceutical Co., Ltd. &nbsp;&nbsp;&nbsp; Aurolab &nbsp;&nbsp;&nbsp; Yichuang &nbsp;&nbsp;&nbsp; Eisai
&nbsp;
The content of the study subjects, includes a total 14 chapters:
&nbsp;
Chapter 1, 2 and 3 describe Indocyanine Green (CAS 3599-32-4) market executive summary, research scope, and detailed research methodology.
Chapter 4 provide Indocyanine Green (CAS 3599-32-4) market dynamics and its impact analysis such as market driving forces, restraining factors, market opportunities, latest trends, PESTLE analysis, porter's five forces analysis, etc.
Chapter 5, 6, and 7 exhibit thorough market size (USD Mn) analysis of type, application and regional segments of Indocyanine Green (CAS 3599-32-4) market, from 2021 to 2033.
Chapter 8, 9, 10, 11, and 12 depict detailed market size (USD Mn) and trends analysis of Indocyanine Green (CAS 3599-32-4) market segments on regional and country level, from 2021 to 2033.
Chapter 13 and 14 showcase competitive landscape analysis of Indocyanine Green (CAS 3599-32-4) market including market share (%) analysis for 2024 and detailed company profiles along with research findings &amp; conclusion.

Indocyanine Green Market

CHAPTER 1 EXECUTIVE SUMMARY &amp; KEY HIGHLIGHTS 1.1 Executive Summary 1.2 Key Highlights CHAPTER 2 INDOCYANINE GREEN (CAS 3599-32-4) MARKET RESEARCH SCOPE 2.1 Market Definition 2.2 Assumptions 2.3 Limitations CHAPTER 3 RESEARCH METHODOLOGY 3.1 Introduction 3.2 Data Capture Sources &nbsp;&nbsp;&nbsp; 3.2.1 Primary Sources &nbsp;&nbsp;&nbsp; 3.2.2 Secondary Sources 3.3 Market Size Estimation &nbsp;&nbsp;&nbsp; 3.3.1 Bottom Up Approach &nbsp;&nbsp;&nbsp; 3.3.2 Top Down Approach 3.4 Market Forecast 3.5 Assumptions and Limitations 3.6 Report Segmentation CHAPTER 4 MARKET DYNAMICS AND IMPACT ANALYSIS 4.1 Market Dynamics Impact Analysis 4.2 Driving Factors &nbsp;&nbsp;&nbsp; 4.2.1 Driver 1 &nbsp;&nbsp;&nbsp; 4.2.2 Driver 2 4.3 Restraining Factors &nbsp;&nbsp;&nbsp; 4.3.1 Restraint 1 &nbsp;&nbsp;&nbsp; 4.3.2 Restraint 2 4.4 Opportunities &nbsp;&nbsp;&nbsp; 4.4.1 Opportunity 1 &nbsp;&nbsp;&nbsp; 4.4.2 Opportunity 2 4.5 Porter's Five Forces Analysis 4.6 PESTLE Analysis CHAPTER 5 INDOCYANINE GREEN (CAS 3599-32-4) MARKET ESTIMATE AND FORECAST BY REGION 5.1 Global Indocyanine Green (CAS 3599-32-4) Market Value by Region: 2021 vs. 2024 vs. 2033 5.2 Global Indocyanine Green (CAS 3599-32-4) Market Scenario by Region (2021-2024) &nbsp;&nbsp;&nbsp; 5.2.1 Global Indocyanine Green (CAS 3599-32-4) Market Value Share by Region (2021-2024) 5.3 Global Indocyanine Green (CAS 3599-32-4) Market Forecasts by Region (2024-2033) &nbsp;&nbsp;&nbsp; 5.3.1 Global Indocyanine Green (CAS 3599-32-4) Market Value Forecasts by Region (2024-2033) 5.4 Geographic Market Analysis: Market Facts &amp; Figures &nbsp;&nbsp;&nbsp; 5.4.1 North America Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections (2021-2033) &nbsp;&nbsp;&nbsp; 5.4.2 Europe Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections (2021-2033) &nbsp;&nbsp;&nbsp; 5.4.3 Asia Pacific Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections (2021-2033) &nbsp;&nbsp;&nbsp; 5.4.4 Latin America Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections (2021-2033) &nbsp;&nbsp;&nbsp; 5.4.5 Middle East &amp; Africa Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections (2021-2033) CHAPTER 6 GLOBAL INDOCYANINE GREEN (CAS 3599-32-4) MARKET, BY TYPE 6.1 Global Indocyanine Green (CAS 3599-32-4) Market Value, by Type (2021-2024) 6.2 Global Indocyanine Green (CAS 3599-32-4) Market Forecast, by Type (2025-2033) &nbsp;&nbsp;&nbsp; 6.2.1 Type I &nbsp;&nbsp;&nbsp; 6.2.2 Type II CHAPTER 7 GLOBAL INDOCYANINE GREEN (CAS 3599-32-4) MARKET, BY APPLICATION 7.1 Global Indocyanine Green (CAS 3599-32-4) Market Value, by Application (2021-2024) 7.2 Global Indocyanine Green (CAS 3599-32-4) Market Forecast, by Application (2025-2033) &nbsp;&nbsp;&nbsp; 7.2.1 Ophthalmology &nbsp;&nbsp;&nbsp; 7.2.2 Neurosurgery &nbsp;&nbsp;&nbsp; 7.2.3 Liver Diseases &nbsp;&nbsp;&nbsp; 7.2.4 Others CHAPTER 8 NORTH AMERICA INDOCYANINE GREEN (CAS 3599-32-4) MARKET FACTS &amp; FIGURES 8.1 North America Indocyanine Green (CAS 3599-32-4) Market Value, by Country (2021-2033) &nbsp;&nbsp;&nbsp; 8.1.1 U.S. &nbsp;&nbsp;&nbsp; 8.1.2 Canada &nbsp;&nbsp;&nbsp; 8.1.3 Mexico 8.2 North America Indocyanine Green (CAS 3599-32-4) Market Value, by Type (2021-2033) &nbsp;&nbsp;&nbsp; 8.2.1 Type I &nbsp;&nbsp;&nbsp; 8.2.2 Type II 8.3 North America Indocyanine Green (CAS 3599-32-4) Market Value, by Application (2021-2033) &nbsp;&nbsp;&nbsp; 8.3.1 Ophthalmology &nbsp;&nbsp;&nbsp; 8.3.2 Neurosurgery &nbsp;&nbsp;&nbsp; 8.3.3 Liver Diseases &nbsp;&nbsp;&nbsp; 8.3.4 Others CHAPTER 9 EUROPE INDOCYANINE GREEN (CAS 3599-32-4) MARKET FACTS &amp; FIGURES 9.1 Europe Indocyanine Green (CAS 3599-32-4) Market Value, by Country (2021-2033) &nbsp;&nbsp;&nbsp; 9.1.1 UK &nbsp;&nbsp;&nbsp; 9.1.2 Germany &nbsp;&nbsp;&nbsp; 9.1.3 France &nbsp;&nbsp;&nbsp; 9.1.4 Spain &nbsp;&nbsp;&nbsp; 9.1.5 Italy &nbsp;&nbsp;&nbsp; 9.1.6 Russia &nbsp;&nbsp;&nbsp; 9.1.7 Rest of Europe 9.2 Europe Indocyanine Green (CAS 3599-32-4) Market Value, by Type (2021-2033) &nbsp;&nbsp;&nbsp; 9.2.1 Type I &nbsp;&nbsp;&nbsp; 9.2.2 Type II 9.3 Europe Indocyanine Green (CAS 3599-32-4) Market Value, by Application (2021-2033) &nbsp;&nbsp;&nbsp; 9.3.1 Ophthalmology &nbsp;&nbsp;&nbsp; 9.3.2 Neurosurgery &nbsp;&nbsp;&nbsp; 9.3.3 Liver Diseases &nbsp;&nbsp;&nbsp; 9.3.4 Others CHAPTER 10 ASIA PACIFIC INDOCYANINE GREEN (CAS 3599-32-4) MARKET FACTS &amp; FIGURES 10.1 Asia Pacific Indocyanine Green (CAS 3599-32-4) Market Value, by Country (2021-2033) &nbsp;&nbsp;&nbsp; 10.1.1 China &nbsp;&nbsp;&nbsp; 10.1.2 Japan &nbsp;&nbsp;&nbsp; 10.1.3 India &nbsp;&nbsp;&nbsp; 10.1.4 South Korea &nbsp;&nbsp;&nbsp; 10.1.5 Australia &nbsp;&nbsp;&nbsp; 10.1.6 Southeast Asia &nbsp;&nbsp;&nbsp; 10.1.7 Rest of Asia Pacific 10.2 Asia Pacific Indocyanine Green (CAS 3599-32-4) Market Value, by Type (2021-2033) &nbsp;&nbsp;&nbsp; 10.2.1 Type I &nbsp;&nbsp;&nbsp; 10.2.2 Type II 10.3 Asia Pacific Indocyanine Green (CAS 3599-32-4) Market Value, by Application (2021-2033) &nbsp;&nbsp;&nbsp; 10.3.1 Ophthalmology &nbsp;&nbsp;&nbsp; 10.3.2 Neurosurgery &nbsp;&nbsp;&nbsp; 10.3.3 Liver Diseases &nbsp;&nbsp;&nbsp; 10.3.4 Others CHAPTER 11 LATIN AMERICA INDOCYANINE GREEN (CAS 3599-32-4) MARKET FACTS &amp; FIGURES 11.1 Latin America Indocyanine Green (CAS 3599-32-4) Market Value, by Country (2021-2033) &nbsp;&nbsp;&nbsp; 11.1.1 Brazil &nbsp;&nbsp;&nbsp; 11.1.2 Argentina &nbsp;&nbsp;&nbsp; 11.1.3 Rest of Latin America 11.2 Latin America Indocyanine Green (CAS 3599-32-4) Market Value, by Type (2021-2033) &nbsp;&nbsp;&nbsp; 11.2.1 Type I &nbsp;&nbsp;&nbsp; 11.2.2 Type II 11.3 Latin America Indocyanine Green (CAS 3599-32-4) Market Value, by Application (2021-2033) &nbsp;&nbsp;&nbsp; 11.3.1 Ophthalmology &nbsp;&nbsp;&nbsp; 11.3.2 Neurosurgery &nbsp;&nbsp;&nbsp; 11.3.3 Liver Diseases &nbsp;&nbsp;&nbsp; 11.3.4 Others CHAPTER 12 MIDDLE EAST &amp; AFRICA INDOCYANINE GREEN (CAS 3599-32-4) MARKET FACTS &amp; FIGURES 12.1 Middle East &amp; Africa Indocyanine Green (CAS 3599-32-4) Market Value, by Country (2021-2033) &nbsp;&nbsp;&nbsp; 12.1.1 Saudi Arabia &nbsp;&nbsp;&nbsp; 12.1.2 UAE &nbsp;&nbsp;&nbsp; 12.1.3 South Africa &nbsp;&nbsp;&nbsp; 12.1.4 Rest of Middle East &amp; Africa 12.2 Middle East &amp; Africa Indocyanine Green (CAS 3599-32-4) Market Value, by Type (2021-2033) &nbsp;&nbsp;&nbsp; 12.2.1 Type I &nbsp;&nbsp;&nbsp; 12.2.2 Type II 12.3 Middle East &amp; Africa Indocyanine Green (CAS 3599-32-4) Market Value, by Application (2021-2033) &nbsp;&nbsp;&nbsp; 12.3.1 Ophthalmology &nbsp;&nbsp;&nbsp; 12.3.2 Neurosurgery &nbsp;&nbsp;&nbsp; 12.3.3 Liver Diseases &nbsp;&nbsp;&nbsp; 12.3.4 Others CHAPTER 13 COMPETITION LANDSCAPE 13.1 Competitive Dashboard 13.2 Company Profiles &nbsp;&nbsp;&nbsp; 13.2.1 Akorn &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.1.1 Business Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.1.2 Financial Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.1.3 Product/Service Portfolio &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.1.4 Recent Development &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.1.5 SWOT Analysis &nbsp;&nbsp;&nbsp; 13.2.2 PULSION Medical Systems AG &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.2.1 Business Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.2.2 Financial Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.2.3 Product/Service Portfolio &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.2.4 Recent Development &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.2.5 SWOT Analysis &nbsp;&nbsp;&nbsp; 13.2.3 Diagnostic Green &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.3.1 Business Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.3.2 Financial Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.3.3 Product/Service Portfolio &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.3.4 Recent Development &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.3.5 SWOT Analysis &nbsp;&nbsp;&nbsp; 13.2.4 SERB &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.4.1 Business Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.4.2 Financial Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.4.3 Product/Service Portfolio &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.4.4 Recent Development &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.4.5 SWOT Analysis &nbsp;&nbsp;&nbsp; 13.2.5 Daiichi Sankyo Company &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.5.1 Business Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.5.2 Financial Overview &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.5.3 Product/Service Portfolio &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.5.4 Recent Development &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.2.5.5 SWOT Analysis &nbsp;&nbsp;&nbsp; 13.2.6 Santen Pharmaceutical Co., Ltd. &nbsp;&nbsp;&nbsp; 13.2.7 Aurolab &nbsp;&nbsp;&nbsp; 13.2.8 Yichuang &nbsp;&nbsp;&nbsp; 13.2.9 Eisai CHAPTER 14 RESEARCH FINDINGS &amp; CONCLUSION

Indocyanine Green (CAS 3599-32-4) Market Global Industry Analysis and Forecast (2024-2033) by Type (Type I, Type II), Application (Ophthalmology, Neurosurgery, Liver Diseases, Others)  and Region